Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Islet

Pancreatic β-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase

  1. Maria Sörhede Winzell1,
  2. Håkan Svensson1,
  3. Sven Enerbäck2,
  4. Kim Ravnskjaer3,
  5. Susanne Mandrup3,
  6. Victoria Esser4,
  7. Peter Arner5,
  8. Marie-Clotilde Alves-Guerra6,
  9. Bruno Miroux6,
  10. Frank Sundler7,
  11. Bo Ahrén8 and
  12. Cecilia Holm1
  1. 1Department of Cell and Molecular Biology, Lund University, Lund, Sweden
  2. 2Department of Molecular Biology, Göteborg University, Göteborg, Sweden
  3. 3Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
  4. 4Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas
  5. 5Department of Medicine, Huddinge University Hospital Karolinska Institute, Stockholm, Sweden
  6. 6CNRS UPR 9078, Meudon, France
  7. 7Department of Physiological Sciences, Lund University, Lund, Sweden
  8. 8Department of Medicine, Lund University, Lund Sweden
  1. Address correspondence and reprint requests to Dr. Maria Sörhede Winzell, Department of Cell and Molecular Biology, Section for Molecular Signaling, Lund University, Biomedical Center (BMC), C11, SE-221 84 Lund, Sweden. E-mail: maria.sorhede_winzell{at}medkem.lu.se
Diabetes 2003 Aug; 52(8): 2057-2065. https://doi.org/10.2337/diabetes.52.8.2057
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Abstract

Lipid perturbations associated with triglyceride overstorage in β-cells impair insulin secretion, a process termed lipotoxicity. To assess the role of hormone-sensitive lipase, which is expressed and enzymatically active in β-cells, in the development of lipotoxicity, we generated transgenic mice overexpressing hormone-sensitive lipase specifically in β-cells. Transgenic mice developed glucose intolerance and severely blunted glucose-stimulated insulin secretion when challenged with a high-fat diet. As expected, both lipase activity and forskolin-stimulated lipolysis was increased in transgenic compared with wild-type islets. This was reflected in significantly lower triglycerides levels in transgenic compared with wild-type islets in mice receiving the high-fat diet, whereas no difference in islet triglycerides was found between the two genotypes under low-fat diet conditions. Our results highlight the importance of mobilization of the islet triglyceride pool in the development of β-cell lipotoxicity. We propose that hormone-sensitive lipase is involved in mediating β-cell lipotoxicity by providing ligands for peroxisome proliferator-activated receptors and other lipid-activated transcription factors, which in turn alter the expression of critical genes. One such gene might be uncoupling protein-2, which was found to be upregulated in transgenic islets, a change that was accompanied by decreased ATP levels.

  • CPT I, carnitine palmitoyltransferase I
  • FFA, free fatty acid
  • GSIS, glucose-stimulated insulin secretion
  • HSL, hormone-sensitive lipase
  • IVGTT, intravenous glucose tolerance test
  • MCAD, medium-chain acyl dehydrogenase
  • PDX-1, pancreatic/duodenal homeobox-1
  • PPAR, peroxisome proliferator-activated receptor
  • UCP2, uncoupling protein 2

Footnotes

    • Accepted May 13, 2003.
    • Received December 13, 2002.
  • DIABETES
View Full Text
PreviousNext
Back to top

In this Issue

August 2003, 52(8)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pancreatic β-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pancreatic β-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase
Maria Sörhede Winzell, Håkan Svensson, Sven Enerbäck, Kim Ravnskjaer, Susanne Mandrup, Victoria Esser, Peter Arner, Marie-Clotilde Alves-Guerra, Bruno Miroux, Frank Sundler, Bo Ahrén, Cecilia Holm
Diabetes Aug 2003, 52 (8) 2057-2065; DOI: 10.2337/diabetes.52.8.2057

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Pancreatic β-Cell Lipotoxicity Induced by Overexpression of Hormone-Sensitive Lipase
Maria Sörhede Winzell, Håkan Svensson, Sven Enerbäck, Kim Ravnskjaer, Susanne Mandrup, Victoria Esser, Peter Arner, Marie-Clotilde Alves-Guerra, Bruno Miroux, Frank Sundler, Bo Ahrén, Cecilia Holm
Diabetes Aug 2003, 52 (8) 2057-2065; DOI: 10.2337/diabetes.52.8.2057
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Vesicular Inhibitory Amino Acid Transporter Is Present in Glucagon-Containing Secretory Granules in αTC6 Cells, Mouse Clonal α-Cells, and α-Cells of Islets of Langerhans
  • Endothelial Differentiation Gene Receptors in Pancreatic Islets and INS-1 Cells
Show more Islet

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.